PARP Cancer Research Results

PARP, poly ADP-ribose polymerase (PARP) cleavage: Click to Expand ⟱
Source:
Type:
Poly (ADP-ribose) polymerase (PARP) cleavage is a hallmark of caspase activation. PARP (Poly (ADP-ribose) polymerase) is a family of proteins involved in a variety of cellular processes, including DNA repair, genomic stability, and programmed cell death. PARP enzymes play a crucial role in repairing single-strand breaks in DNA.
PARP has gained significant attention, particularly in the treatment of certain types of tumors, such as those with BRCA1 or BRCA2 mutations. These mutations impair the cell's ability to repair double-strand breaks in DNA through homologous recombination. Cancer cells with these mutations can become reliant on PARP for survival, making them particularly sensitive to PARP inhibitors.
PARP inhibitors, such as olaparib, rucaparib, and niraparib, have been developed as targeted therapies for cancers associated with BRCA mutations.

PARP Family:
The poly (ADP-ribose) polymerases (PARPs) are a family of enzymes involved in a number of cellular processes, including DNA repair, genomic stability, and programmed cell death.
PARP1 is the predominant family member responsible for detecting DNA strand breaks and initiating repair processes, especially through base excision repair (BER).

PARP1 Overexpression:
In several cancer types—including breast, ovarian, prostate, and lung cancers—elevated PARP1 expression and/or activity has been reported.
High PARP1 expression in certain cancers has been associated with aggressive tumor behavior and resistance to therapies (especially those that induce DNA damage).
Increased PARP1 activity may correlate with poorer overall survival in tumors that rely on DNA repair for survival.


Scientific Papers found: Click to Expand⟱
8641- MBZ,  ONC201,    The therapeutic potential of repurposed mebendazole, alone and in synergistic combination with ONC201, in the treatment of diffuse midline glioma
- in-vitro, GBM, NA
TumCCA↑, P21↑, p27/CDKN1B↑, Apoptosis↑, Casp3↑, cl‑PARP↑, Synergy↑, ChemoSen↑,
8648- MBZ,    Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- Review, Var, NA
angioG↓, MMPs↓, MDR1↓, TubPol↓, RadioS?, ChemoSen?, TumCG↓, TumMeta?, OS↑, BioAv↓, BioAv↑, BBB↑, mitA↑, HH↓, Shh↓, Synergy↑, Gli1↓, PTCH2↓, XIAP↓, cl‑PARP↑, Casp3↑, BRAF↓, MEK↓, SYN1↑, Cyt‑c↑, TumVol↓, VEGFR2/KDR/Flk1↓, VEGF↓, VCAM-1↓, DYRK1B↓, QoL↑, Dose↝,
8822- MCP,    Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3
- vitro+vivo, CRC, T24/HTB-9 - in-vitro, Bladder, J82
TumCCA↑, cycD1/CCND1↓, p‑cDC2↓, Casp3↑, cl‑Casp3↑, cl‑PARP↑, Gal-3↓, Akt↓, TumCG↓, Ki-67↓, Dose⇅,
8756- MeSA,    THE MAIN CYTOTOXIC EFFECTS OF METHYLSELENINIC ACID ON VARIOUS CANCER CELLS
- Review, Var, NA
ROS↑, GSH↓, RadioS↑, angioG↓, p‑Akt↓, IκB↓, NF-kB↓, ITGB3↓, p‑FOXO3↓, BAX↑, Cyt‑c↑, proCasp3↑, PARP↑, Glycolysis↓, TCA↓, NRF2↑, DNMT1↓, Hif1a↓, ER Stress↑, ChemoSen↑,
8742- MeSA,    Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells
- in-vitro, Pca, DU145
TumCCA↑, DNAdam↑, Casp↑, cl‑PARP↑, p27/CDKN1B↑, P21↑, Apoptosis↑, Akt↓, ERK↓,
2375- MET,    Metformin inhibits gastric cancer via the inhibition of HIF1α/PKM2 signaling
- in-vitro, GC, SGC-7901
tumCV↓, TumCI↓, TumCMig↓, Apoptosis↑, PARP↓, PI3K↓, Akt↓, Hif1a↓, PKM2↓, COX2/PTGS2↓,
2374- MET,    Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions
- in-vitro, BC, MCF7 - in-vitro, BC, SkBr3 - in-vitro, BC, MDA-MB-231
eff↑, Apoptosis↑, Glycolysis↓, PKM2↓, mTOR↓, PARP↓,
3486- MF,    Pulsed electromagnetic field potentiates etoposide-induced MCF-7 cell death
- in-vitro, BC, MCF-10AT
ChemoSen↑, tumCV↓, cl‑PARP↑, Casp7↑, Casp9↑, survivin↓, BAX↑, DNAdam↑, ROS↑, eff↓,
496- MF,    Low-Frequency Magnetic Fields (LF-MFs) Inhibit Proliferation by Triggering Apoptosis and Altering Cell Cycle Distribution in Breast Cancer Cells
- in-vitro, BC, MCF7 - in-vitro, BC, ZR-75-1 - in-vitro, BC, T47D - in-vitro, BC, MDA-MB-231
ROS↑, PI3K↓, Akt↓, GSK‐3β↑, Apoptosis↑, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, CycB/CCNB1↓, TumCCA↑, p‑Akt↓, TumCP↓, selectivity↑, eff↓,
4353- MF,  Chemo,    Pulsed Electromagnetic Field Enhances Doxorubicin-induced Reduction in the Viability of MCF-7 Breast Cancer Cells
- in-vitro, BC, MCF7
TumCCA↑, Apoptosis↑, ChemoSen↑, TumCCA↑, Casp↝, p‑CDK2↓, cycE/CCNE↓, Fas↑, BAX↑, survivin↓, Mcl-1↓, cl‑PARP↑, cl‑Casp7↑, cl‑Casp8↑, cl‑Casp9↑,
9087- MGF,    Mangiferin in human disease: Multifaceted mechanisms and applications (Review)
- Review, Var, NA
TumCP↓, TumCI↓, angioG↓, *BioAv↓, *neuroP↑, *Inflam↓, *AntiCan↑, *ROS↓, *BioAv↑, *BioAv↝, *Half-Life↝, *BBB↓, CDK1↑, CycB/CCNB1↑, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, cl‑PARP↑, PI3K↓, Akt↓, mTOR↓, MMP↓, MOMP↑, Apoptosis↑, lipid-P↑, TCA↓, NRF2↑, NQO1↑, ROS↓, RadioS↑,
8898- MOR,    Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells
- in-vitro, Cerv, HeLa
TumCP↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, WEE1↑, CDK1↓, CDC25↓, survivin↓, CycB/CCNB1↓, Chk2↓, BAX↑, BAD↑, Cyt‑c↑, APAF1↑, Casp9↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, FasL↑, FADD↑, Casp10↑, PARP↑, PI3K↑, Akt↑, mTOR↑, p70S6↑, Diablo↑, Bcl-2↓, Bcl-xL↓, AMPK↓, IAP1↓, NF-kB↓, ROS↑,
8863- MOR,    Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect
- in-vitro, Colon, SW48
TumCP↓, Apoptosis↑, ROS↑, MMP↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, BAX↑, Bcl-2↓, ATP↓, GlucoseCon↓, GLUT1↓, Warburg↓, Dose↝, Catalase↓, GSH↓, ADP:ATP↑, AMP↑,
8892- MOR,  Cisplatin,    Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma
- vitro+vivo, HCC, NA
PARP↓, HMGB1↓, ChemoSen↑,
8886- MOR,  doxoR,    Morin overcomes doxorubicin resistance in human breast cancer by inducing DNA damage and modulating the LKB1/AMPK/mTORC1 signaling pathway
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7
DNAdam↑, DNArepair↓, TumCCA↑, cycD1/CCND1↓, CDK4↓, cycE/CCNE↓, CycB/CCNB1↓, PARP↓, Bcl-xL↓, p‑AMPK↑, p‑STK11/LKB1↑, p‑mTOR↓, p‑Akt↓, p‑GSK‐3β↓, tumCV↓,
8859- MOR,    Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1
- in-vitro, Melanoma, U266 - in-vitro, BC, MCF7 - in-vitro, SCC, SCC4 - in-vitro, BC, MCF-10AT
STAT3↓, Src↓, JAK1↓, JAK2↓, PIAS-3↑, ChemoSen↑, SHP1↑, XIAP↓, cFLIP↓, Mcl-1↓, survivin↓, Bcl-2↓, Bcl-xL↓, IAP2/BIRC3↓, Casp8↑, Casp9↑, Casp3↑, cl‑PARP↑, selectivity↑,
8780- MSM,    Methylsulfonylmethane Induces Cell Cycle Arrest and Apoptosis, and Suppresses the Stemness Potential of HT-29 Cells
- in-vitro, CRC, HT-29
Apoptosis↑, TumCCA↑, CSCs↓, Dose↝, cl‑PARP↑, cl‑Casp9↑, MMP↓, SOX2↓, OCT4↓, Nanog↓,
8775- MSM,    Methylsulfonylmethane Induces p53 Independent Apoptosis in HCT-116 Colon Cancer Cells
- Review, Colon, HCT116
*AntiArt↑, *ROS↓, tumCV↓, Apoptosis↑, PARP↑, Casp3↑, p‑JNK↑, eff↝, *toxicity↓, ChemoSen↑, TumCP↓,
8766- MSM,    Methylsulfonylmethane suppresses hepatic tumor development through activation of apoptosis
- vitro+vivo, Liver, HepG2 - in-vitro, Liver, HUH7
TumCG↓, Apoptosis↑, cl‑Casp8↑, cl‑Casp3↑, cl‑PARP↑, TumVol↓, AST↓, ALAT↓,
8804- MT/VAE,    Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells
- in-vitro, lymphoma, U937
DNAdam↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, cl‑PKCδ↑, Apoptosis↑,
8936- MushCha,    Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis
- vitro+vivo, Lung, LLC1
AMPK↑, tumCV↓, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, MMP↓, OXPHOS↓, Glycolysis↓, Dose?, MPT↑, ATP↓,
8968- mushLions,    Mechanism of Hericium erinaceus (Yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells
- in-vitro, lymphoma, U937
Ingr?, Apoptosis↑, TumCP↓, Casp3↑, Casp9↑, Bcl-2↓, Bcl-xL↓, XIAP↓, IAP1↓, Cyt‑c↑, MMP↓, cl‑PARP↑,
1128- Myr,    Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
- vitro+vivo, Ovarian, NA
MAPK↓, ERK↓, PI3K↓, Akt↓, p‑PARP↑, cl‑Casp3↑, Bax:Bcl2↑, TumCMig↓, SMAD3↓,
6492- Nimb,    Review on Molecular and Chemopreventive Potential of Nimbolide in Cancer
- Review, Var, NA
Apoptosis↑, TumCCA↑, TumCP↓, TumCI↓, angioG↓, TumMeta↓, PTEN↑, NF-kB↓, Wnt↓, β-catenin/ZEB1↓, IKKα↓, CXCR2↓, CXCR4↓, Bcl-2↓, COX2/PTGS2↓, MMP9↓, VEGF↓, TIMP2↑, chemoPv↑, ROS↑, DR4↑, P53↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, Mcl-1↓, XIAP↓, survivin↓, FasL↑, FADD↑, EGFR↓, MMPs↓,
6489- Nimb,    Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model
- in-vivo, Pca, DU145 - in-vivo, Pca, LNCaP
tumCV↓, Apoptosis↑, TumCI↓, TumCMig↓, STAT3↓, ROS↑, TumCG↓, TumMeta↓, TumCCA↑, DNAdam↑, Casp3↑, Casp7↑, cl‑PARP↑, p‑STAT3↓, IL6↓, GSR↓,
4976- Nimb,    Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition
- vitro+vivo, PC, NA
ROS↑, Apoptosis↑, TumAuto↑, TumCP↓, TumCMig↓, TumCI↓, EMT↓, Dose↓, selectivity↑, Akt↓, eff↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, Bcl-2↓,
4977- Nimb,    Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis
- vitro+vivo, PC, AsPC-1 - in-vitro, PC, PANC1
SOD2↑, TumCG↓, TumMeta↓, ROS↑, Apoptosis↑, PI3K↓, Akt↓, EMT↓, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑PARP↑, Bcl-2↓,
150- NRF,  CUR,  docx,    Subverting ER-Stress towards Apoptosis by Nelfinavir and Curcumin Coexposure Augments Docetaxel Efficacy in Castration Resistant Prostate Cancer Cells
- in-vitro, Pca, C4-2B
p‑Akt↓, p‑eIF2α↑, ER Stress↑, ATF4↑, CHOP/DDIT3↑, TRIB3↑, ChemoSen↑, Casp3↑, cl‑PARP↑, BID↑, XBP-1↑,
4643- OLE,  HT,    Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
- Review, Var, NA
TumCCA↑, Apoptosis↑, ER Stress↑, UPR↑, CHOP/DDIT3↑, ROS↑, Bcl-2↓, NOX4↑, Hif1a↓, MMP2↓, MMP↓, VEGF↓, Akt↓, NF-kB↓, p65↓, SIRT3↓, mTOR↓, Catalase↓, SOD2↓, FASN↓, STAT3↓, HDAC2↓, HDAC3↓, BAD↑, BAX↑, Bak↑, Casp3↑, Casp9↑, PARP↑, P53↑, P21↑, p27/CDKN1B↑, Half-Life↝, BioAv↓, BioAv↓, selectivity↑, RadioS↑, *ROS↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *chemoP↑, *Inflam↓, PPARγ↑,
8427- OM,    Mitotic arrest and apoptosis in breast cancer cells induced by Origanum majorana extract: upregulation of TNF-α and downregulation of survivin and mutant p53
- in-vitro, BC, MDA-MB-231
tumCV↓, Dose↝, mitA↑, Apoptosis↑, TNF-α↑, Casp3↑, Casp8↑, cl‑PARP↑, survivin↓, p53 Wildtype↓, P21↑, ac‑H3↑, ac‑H4↑, γH2AX↑, DNAdam↑, TumCCA↑,
9046- PatchO,    Patchouli alcohol suppresses castration-resistant prostate cancer progression by inhibiting NF-κB signal pathways
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
TumCMig↓, TumCI↓, TumCP↓, Apoptosis↑, MMP↓, cl‑Casp3↑, cl‑PARP↑, BAX↑, Bcl-2↓, Ki-67↓, Mcl-1↓, NF-kB↓, p65↓, MMP2↓, MMP7↓, MMP9↓, VEGF↓, TumCG↓, Dose↝,
2070- PB,    Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB IN HT-29 colon cancer cells
- in-vitro, CRC, HT-29
TumCG↓, Apoptosis↑, MMP↓, Casp3↑, PARP↓, NF-kB↓, eff↑,
2057- PB,    Trichomonas vaginalis induces apoptosis via ROS and ER stress response through ER–mitochondria crosstalk in SiHa cells
- in-vitro, Cerv, SiHa
ROS↓, tumCV∅, cl‑PARP↓, cl‑Casp3↓, MMP∅, ER Stress↓,
1674- PBG,  SDT,  HPT,    Study on the effect of a triple cancer treatment of propolis, thermal cycling-hyperthermia, and low-intensity ultrasound on PANC-1 cells
- in-vitro, PC, PANC1 - in-vitro, Nor, H6c7
tumCV↓, ROS↑, eff↑, Dose∅, selectivity↑, MMP↓, mtDam↑, cl‑PARP↑, p‑ERK↓, p‑JNK↑, p‑p38↑, eff↓, ChemoSen↑,
1676- PBG,    Use of Stingless Bee Propolis and Geopropolis against Cancer—A Literature Review of Preclinical Studies
- Review, Var, NA
ROS↑, MMP↓, Bcl-2↓, Synergy↑, tumCV↓, TumCCA↑, angioG↓, PAK1↓, HDAC1↓, HDAC2↓, P53↑, PCNA↓, cycD1/CCND1↓, cycE/CCNE↓, P21?, BAX↑, cl‑Casp3↑, cl‑PARP↑, ChemoSen↑,
1682- PBG,    Honey, Propolis, and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits
- Review, Var, NA
i-LDH↓, Akt↓, MAPK↓, NF-kB↓, IL1β↓, IL6↓, TNF-α↓, iNOS↓, COX2/PTGS2↓, ROS↓, Bcl-2↓, PARP↓, P53↑, BAX↑, Casp3↑, TumCCA↑, Cyt‑c↑, MMP↓, eff↑,
1664- PBG,    Anticancer Activity of Propolis and Its Compounds
- Review, Var, NA
Apoptosis↑, TumCMig↓, TumCCA↑, TumCP↓, angioG↓, P21↑, p27/CDKN1B↑, CDK1↓, p‑CDK1↓, cycA1/CCNA1↓, CycB/CCNB1↓, P70S6K↓, CLDN2↓, HK2↓, PFK↓, PKM2↓, LDHA↓, TLR4↓, H3↓, α-tubulin↓, ROS↑, Akt↓, GSK‐3β↓, FOXO3↓, NF-kB↓, cycD1/CCND1↓, MMP↓, ROS↑, i-Ca+2↑, lipid-P↑, ER Stress↑, UPR↑, PERK↑, eIF2α↑, GRP78/BiP↑, BAX↑, PUMA↑, ROS↑, MMP↓, Cyt‑c↑, cl‑Casp8↑, cl‑Casp8↑, cl‑Casp3↑, cl‑PARP↑, eff↑, eff↑, RadioS↑, ChemoSen↑, eff↑,
4957- PEITC,    Phenethyl Isothiocyanate (PEITC) from Cruciferous Vegetables Targets Human Cancer Stem-Like Cells
- vitro+vivo, Cerv, HeLa
CSCs↓, ALDH↓, CD44↓, CD24↓, cl‑PARP↑, DR4↑, DR5↑,
4960- PEITC,    Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells
- in-vivo, Cerv, HeLa
CD44↓, CD24↓, CSCs↓, cl‑PARP↑, DR4↑, DR5↑, TumCP↓,
4929- PEITC,  PacT,    Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
ChemoSen↑, Apoptosis↑, TumCCA↑, Synergy↑, CDK1↓, Bcl-2↓, BAX↑, cl‑PARP↑, SAL↑,
5184- PEITC,    Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways
- vitro+vivo, AML, U937
Casp3↑, Casp9↑, Casp8↑, cl‑PARP↑, Apoptosis↑, Mcl-1↓, Akt↓, JNK↑, eff↑,
1768- PG,    Propyl gallate reduces the growth of lung cancer cells through caspase‑dependent apoptosis and G1 phase arrest of the cell cycle
- in-vitro, Lung, Calu-6 - in-vitro, Lung, A549
TumCG↓, TumCCA↑, Dose∅, Bcl-2↓, cl‑PARP↑, MMP↓, Casp3↑, Casp8↑,
5218- PG,    Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy
- in-vitro, HCC, Hep3B
TumCP↓, Apoptosis↑, ROS↑, TumAuto↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, BAD↑, Bcl-2↓, toxicity↓, hepatoP↑, GSH↓,
5219- PG,    Propyl gallate inhibits the growth of HeLa cells via caspase-dependent apoptosis as well as a G1 phase arrest of the cell cycle
- in-vitro, Cerv, HeLa
TumCG↓, TumCCA↑, p27/CDKN1B↑, Apoptosis↑, MMP↓, Casp3↑, Casp8↑, cl‑PARP↑,
9027- Phyco,  5-FU,    C-Phycocyanin-Cisplatin Combination Targeting Redox Balance for Enhanced Efficacy Against Glioblastoma Cells
- in-vivo, GBM, U87MG
tumCV↓, selectivity↑, ChemoSen↑, Apoptosis↑, DNAdam↑, cl‑Casp3↑, cl‑PARP↑, ROS↓, SOD2↑, Catalase↑,
5208- PI,    Piperine Inhibits Cell Proliferation and Induces Apoptosis of Human Gastric Cancer Cells by Downregulating Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway
- in-vitro, GC, SNU16 - in-vitro, Nor, GES-1
TumCP↓, Apoptosis↑, BAX↑, BAD↑, Cyt‑c↑, cl‑PARP↑, cl‑Casp3↑, Bcl-2↓, Bcl-xL↓, p‑PI3K↓, p‑Akt↓, Ki-67↓, toxicity↓, RadioS↑,
5216- PI,  doxoR,    Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells
- vitro+vivo, BC, MDA-MB-231
ChemoSen↑, necrosis↑, PTEN↓, PI3K↓, p‑Akt↓, mTOR↓, ALDH↓, TumVol↓, OS↑, cardioP↑, cl‑PARP↑,
2944- PL,    Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells
- in-vitro, Thyroid, IHH4 - in-vitro, Thyroid, 8505C - in-vivo, NA, NA
ROS↑, selectivity↑, tumCV↓, TumCCA↑, Apoptosis↑, ERK↑, Akt↓, mTOR↓, neuroP↑, Bcl-2↓, Casp3↑, PARP↑, JNK↑, *toxicity↓, eff↓, TumW↓,
2946- PL,    Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
- Review, Var, NA
ROS↑, GSH↓, DNAdam↑, ChemoSen↑, RadioS↑, BioEnh↑, selectivity↑, BioAv↓, eff↑, p‑Akt↓, mTOR↓, GSK‐3β↓, β-catenin/ZEB1↓, HK2↓, Glycolysis↓, Cyt‑c↑, Casp9↑, Casp3↑, Casp7↑, cl‑PARP↑, TrxR↓, ER Stress↑, ATF4↝, CHOP/DDIT3↑, Prx4↑, NF-kB↓, cycD1/CCND1↓, CDK4↓, CDK6↓, p‑RB1↓, RAS↓, cMyc↓, TumCCA↑, selectivity↑, STAT3↓, NRF2↑, HO-1↑, PTEN↑, P-gp/ABCB1↓, MDR1↓, MRP1/ABCC1↓, survivin↓, Twist↓, AP-1↓, Sp1/3/4↓, STAT1↓, STAT6↓, SOX4↑, XBP-1↑, P21↑, eff↑, Inflam↓, COX2/PTGS2↓, IL6↓, MMP9↓, TumMeta↓, TumCI↓, ICAM-1↓, CXCR4↓, VEGF↓, angioG↓, Half-Life↝, BioAv↑,
2956- PL,    Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis
- in-vitro, PC, NA
ROS↑, Ferroptosis↓, GSH↓, GPx↓, cl‑PARP∅, cl‑Casp3∅, eff↑, eff↑,

Showing Research Papers: 351 to 400 of 480
Prev Page 8 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 480

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 2,   NA↑, 2,   NA⇅, 1,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 2,   ARE/EpRE↑, 1,   Catalase↓, 5,   Catalase↑, 3,   Copper↑, 1,   ENOX2↓, 1,   Fenton↑, 3,   GPx↓, 3,   GPx↑, 2,   GPx1↓, 1,   GPx4↓, 3,   GSH↓, 31,   GSH↑, 5,   i-GSH∅, 1,   GSH/GSSG↓, 2,   GSR↓, 2,   GSR↑, 2,   GSSG↑, 2,   GSTs↓, 2,   GSTs↑, 2,   H2O2↑, 5,   i-H2O2↑, 1,   HO-1↓, 10,   HO-1↑, 11,   HO-2↓, 1,   Iron↑, 2,   i-Iron↑, 1,   Keap1↓, 2,   lipid-P?, 1,   lipid-P↓, 1,   lipid-P↑, 11,   MDA↓, 2,   MDA↑, 4,   MPO↓, 1,   NOX4↑, 1,   NQO1↓, 3,   NQO1↑, 2,   NRF2↓, 18,   NRF2↑, 19,   p‑NRF2↑, 1,   Prx↓, 1,   Prx4↑, 1,   PrxII↓, 1,   RNS↑, 2,   ROS?, 3,   ROS↓, 22,   ROS↑, 235,   ROS⇅, 10,   ROS↝, 1,   ROS∅, 2,   i-ROS↑, 2,   mt-ROS↑, 7,   SOD↓, 6,   SOD↑, 4,   SOD1↓, 1,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 2,   TAC↑, 2,   Thiols↓, 1,   Trx↓, 2,   ox-Trx1↑, 1,   TrxR↓, 7,   TrxR1↓, 6,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   IronCh↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 7,   CDC25↓, 15,   EGF↓, 4,   ETC↓, 3,   MFN2↑, 1,   mitResp↓, 2,   MKK7↓, 1,   mtDam↑, 20,   OCR↓, 3,   OCR↑, 1,   OXPHOS↓, 5,   mt-OXPHOS↓, 2,   PDH↓, 2,   PDH↝, 1,   p‑PDH↑, 1,   PINK1↑, 3,   SDH↓, 1,   SIRT3↓, 1,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 1,   ACC↑, 3,   p‑ACC↑, 2,   ALAT↓, 4,   ALDOA↓, 2,   AMP↑, 1,   AMPK↓, 2,   AMPK↑, 24,   p‑AMPK↑, 2,   p‑AMT/GCST/T-protein↑, 1,   ATP↓, 15,   ATP↑, 1,   CAIX/CA9↓, 2,   citrate↓, 1,   CPT1A↓, 1,   ECAR↝, 1,   ENO1↓, 3,   FASN↓, 4,   FASN↑, 1,   FBPase↑, 1,   GAPDH↓, 2,   glucoNG↓, 1,   glucoNG↑, 1,   glucose↓, 2,   GlucoseCon↓, 9,   GlutMet↓, 1,   Glycolysis↓, 24,   GSK‐3β↓, 9,   GSK‐3β↑, 5,   p‑GSK‐3β↓, 8,   H2S↑, 1,   HK1↓, 1,   HK2↓, 14,   HMG-CoA↓, 1,   lactateProd↓, 12,   LDHA↓, 6,   LDL↓, 2,   lipidLev↓, 1,   MCT4↓, 1,   NAD↓, 2,   NADPH↓, 1,   NADPH↑, 2,   O-Glc↓, 1,   PCK1↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 8,   PDKs↓, 1,   PFK↓, 3,   PFK2?, 1,   PGK1↓, 1,   PKM2↓, 14,   PKM2∅, 1,   PLA2↓, 1,   PPP↓, 1,   SIRT1↓, 9,   SIRT1↑, 2,   TCA↓, 4,   TS↓, 1,   TumCM/A↓, 1,   Warburg↓, 6,   β-oxidation↓, 2,  

Cell Death(tgid=5) ⓘ

14-3-3 proteins↓, 1,   AIF↑, 13,   APAF1↑, 11,   Apoptosis?, 1,   Apoptosis↓, 9,   Apoptosis↑, 265,   mt-Apoptosis↑, 2,   ASC↓, 1,   BAD↓, 3,   BAD↑, 21,   p‑BAD↓, 2,   Bak↓, 1,   Bak↑, 14,   BAX↓, 4,   BAX↑, 156,   BAX↝, 1,   BAX∅, 1,   Bax:Bcl2↑, 44,   Bcl-2↓, 175,   Bcl-2↑, 6,   Bcl-2↝, 1,   Bcl-2∅, 2,   cl‑Bcl-2↓, 1,   cl‑Bcl-2↑, 1,   Bcl-xL↓, 54,   Bcl-xL↑, 2,   Bcl-xL∅, 1,   BID↑, 11,   cl‑BID↑, 2,   BIM↑, 10,   Casp↑, 39,   Casp↝, 2,   cl‑Casp↑, 2,   Casp1↓, 1,   Casp1↑, 2,   Casp10↑, 3,   Casp12?, 1,   Casp12↑, 3,   Casp2↑, 1,   Casp3?, 1,   Casp3↓, 3,   Casp3↑, 222,   Casp3↝, 1,   Casp3∅, 1,   cl‑Casp3↓, 1,   cl‑Casp3↑, 102,   cl‑Casp3⇅, 1,   cl‑Casp3∅, 1,   proCasp3↓, 5,   proCasp3↑, 5,   Casp6↓, 1,   Casp6↑, 3,   Casp7↑, 30,   cl‑Casp7↑, 12,   Casp8↓, 2,   Casp8↑, 62,   Casp8∅, 2,   cl‑Casp8↑, 24,   proCasp8↓, 1,   proCasp8↑, 4,   Casp9?, 1,   Casp9↓, 2,   Casp9↑, 131,   Casp9∅, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 39,   proCasp9↓, 1,   proCasp9↑, 4,   cFLIP↓, 8,   Cyt‑c↓, 3,   Cyt‑c↑, 132,   Cyt‑c↝, 2,   Cyt‑c?, 1,   Diablo↑, 12,   DR5↑, 30,   Endon↑, 1,   FADD↑, 9,   Fas↓, 1,   Fas↑, 21,   FasL↑, 10,   Ferroptosis↓, 1,   Ferroptosis↑, 5,   GRP58↓, 1,   GSDME↑, 1,   cl‑GSDME↑, 1,   HEY1↓, 2,   IAP1↓, 12,   IAP2/BIRC3↓, 5,   IAP2/BIRC3↑, 1,   cl‑IAP2/BIRC3↑, 1,   ICAD↓, 2,   ICD↑, 1,   iNOS↓, 12,   Mcl-1?, 1,   Mcl-1↓, 36,   Mcl-1↑, 1,   cl‑Mcl-1↑, 1,   MDM2↓, 11,   MDM2↑, 2,   p‑MDM2↓, 2,   MLKL↑, 2,   p‑MLKL↓, 1,   MOMP↓, 1,   MOMP↑, 2,   Necroptosis↑, 4,   necrosis↑, 8,   NOXA↑, 5,   p38↓, 2,   p38↑, 18,   p‑p38↓, 4,   p‑p38↑, 10,   PDCD4↑, 1,   PUMA↑, 10,   Pyro↑, 4,   RIP3↓, 1,   RIP3↑, 2,   p‑RIP3↑, 2,   survivin↓, 74,   TNFR 1↑, 2,   TRAIL↑, 3,   TRAILR↑, 2,   TumCD↓, 1,   TumCD↑, 23,   XIAP?, 1,   XIAP↓, 37,   XIAP↑, 1,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 124,   Akt↑, 4,   p‑Akt↓, 50,   AKT1↓, 1,   BRAF↓, 2,   CaMKII ↓, 2,   CIP2A↓, 1,   CK2↓, 4,   cMET↓, 1,   p‑cMET↑, 1,   p‑CREB↓, 1,   p‑CREB↑, 1,   cSrc↓, 6,   DYRK1B↓, 1,   EF-1α↓, 1,   EGFR↓, 29,   EGFR↑, 2,   p‑EGFR↓, 1,   ERK↓, 38,   ERK↑, 12,   p‑ERK↓, 21,   p‑ERK↑, 7,   FGFR1↓, 3,   FGFR2↓, 1,   HER2/EBBR2↓, 14,   HGF/c-Met↓, 3,   IGF-1R↓, 4,   IGF-1R↑, 1,   IGFR↓, 2,   IKKα↓, 7,   IKKα↑, 1,   ILK↓, 1,   IκB↓, 3,   IκB↑, 1,   p‑IκB↓, 1,   JAK↓, 2,   JAK1?, 1,   JAK1↓, 8,   JAK1↑, 1,   p‑JAK1↓, 2,   JAK2↓, 10,   p‑JAK2↓, 5,   JNK↓, 2,   JNK↑, 25,   p‑JNK↓, 2,   p‑JNK↑, 10,   cl‑JNK↑, 1,   MAPK↓, 31,   MAPK↑, 10,   MAPK↝, 1,   p‑MAPK↓, 1,   p‑MAPK↑, 1,   MEK↓, 5,   p‑MEK↓, 1,   p‑MEK↑, 1,   MKK4↓, 1,   mTOR↓, 61,   mTOR↑, 4,   mTOR↝, 1,   p‑mTOR↓, 13,   mTORC2↓, 4,   p70S6↓, 2,   p70S6↑, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   PDGFR-BB↓, 1,   p‑PDGFR-BB↓, 1,   PI3K↓, 89,   PI3K↑, 1,   p‑PI3K↓, 8,   PI3K/Akt↓, 3,   PI3k/Akt/mTOR↓, 1,   PIAS-3↑, 1,   PKA↓, 1,   PKCδ↓, 8,   p‑PKCδ↓, 1,   cl‑PKCδ↑, 1,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↓, 4,   PTEN↑, 21,   p‑PTEN↓, 1,   Raf↓, 4,   c-Raf↓, 1,   RAS↓, 11,   RIP1↓, 2,   RSK2/RPS6KA3/p90RSK2↓, 1,   RTK-RAS↓, 1,   SHP1↑, 4,   Sp1/3/4↓, 7,   Src↓, 3,   p‑Src↓, 1,   STAT↓, 2,   p‑STAT↓, 1,   STAT3↓, 60,   STAT3↑, 2,   p‑STAT3↓, 18,   p‑STAT3↑, 1,   STAT5↓, 2,   STAT6↓, 2,   p‑STAT6↓, 1,   STK11/LKB1↑, 1,   p‑STK11/LKB1↑, 2,   THEM4/CTMP↑, 1,   TK1↓, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF1↓, 1,   ATF2↓, 1,   ATF3↑, 2,   ATF4↓, 1,   ATF4↑, 15,   ATF4↝, 1,   CBP↓, 1,   cJun↓, 6,   cJun↑, 4,   cMyc↓, 35,   cMyc↑, 1,   p‑cMyc↑, 1,   DNMT1↓, 7,   DNMT3A↓, 2,   DNMTs↓, 3,   EZH2↓, 2,   FOXM1↓, 3,   FOXO1↑, 2,   FOXO3↓, 3,   FOXO3↑, 4,   FOXO3↝, 1,   p‑FOXO3↓, 1,   FOXO4↑, 2,   H3↓, 4,   H3↑, 2,   p‑H3↓, 2,   ac‑H3↑, 1,   H4↓, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 4,   HATs↑, 1,   HDAC↓, 16,   HDAC1↓, 4,   HDAC2↓, 4,   HDAC3↓, 3,   HDAC8↓, 1,   HES1↓, 2,   miR-134↑, 1,   miR-139-5p↑, 1,   miR-200b↑, 1,   miR-205↑, 1,   miR-21↓, 5,   miR-21↑, 1,   miR-21↝, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 1,   miR-29b↓, 1,   miR-339-5p↝, 1,   miR-340↑, 1,   miR-34a↑, 1,   miR-34b-5p↑, 1,   miR-384↑, 1,   Myc↓, 4,   MYCN↓, 1,   OCT4↓, 6,   other↓, 1,   other↑, 1,   other⇅, 1,   other↝, 7,   PhotoS↑, 1,   SOX2↓, 3,   SOX4↓, 1,   SOX4↑, 1,   SOX9↓, 1,   SUV39H↓, 2,   TCF-4↓, 1,   TFAP2A↓, 1,   tumCV↓, 78,   tumCV∅, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 3,   CHOP/DDIT3↑, 37,   cl‑CHOP/DDIT3↑, 1,   eIF2α↓, 1,   eIF2α↑, 7,   p‑eIF2α↑, 9,   ER Stress↓, 1,   ER Stress↑, 55,   GRP78/BiP↓, 1,   GRP78/BiP↑, 18,   HSF1↓, 1,   HSP27↓, 5,   HSP27↑, 1,   HSP27↝, 1,   HSP70/HSPA5↓, 9,   HSP70/HSPA5↑, 2,   HSP70/HSPA5↝, 1,   HSP72↓, 1,   HSP90↓, 11,   HSPs↓, 1,   IRE1↑, 6,   p‑IRE1↑, 1,   PDI↑, 1,   PERK↑, 10,   Proteasome↓, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 12,   XBP-1↓, 2,   XBP-1↑, 4,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↓, 1,   ATG3↑, 4,   ATG5↑, 12,   ATG7↑, 3,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 20,   CTSB↓, 1,   CTSD↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 6,   LC3A↑, 1,   LC3B↑, 2,   LC3B-II↑, 5,   LC3I↓, 1,   LC3I↑, 1,   LC3II↓, 1,   LC3II↑, 14,   LC3s↑, 1,   lysoMP↑, 1,   MitoP↑, 1,   p62↓, 10,   p62↑, 5,   PARK2↑, 3,   RUBCN↓, 1,   SESN2↑, 1,   TumAuto↑, 46,   TumAuto⇅, 1,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↑, 1,   ATM↑, 1,   p‑ATM↑, 2,   BRCA1↓, 1,   BRCA1↑, 1,   BRCA2↓, 1,   DFF45↓, 2,   DFF45↑, 3,   DNA-PK↑, 1,   DNAdam↓, 4,   DNAdam↑, 73,   DNArepair↓, 4,   ERCC1↓, 1,   ERCC4/XPF↓, 1,   hTERT/TERT↓, 7,   Ku70/XRCC6↓, 1,   MGMT↓, 1,   p16↑, 1,   P53?, 1,   P53↓, 6,   P53↑, 82,   p‑P53↓, 1,   p‑P53↑, 8,   ac‑P53↑, 1,   p53 Wildtype↓, 1,   PARP↓, 22,   PARP↑, 89,   PARP↝, 4,   PARP∅, 1,   p‑PARP↑, 6,   cl‑PARP↓, 6,   cl‑PARP↑, 338,   cl‑PARP↝, 1,   cl‑PARP∅, 2,   proPARP↓, 2,   PCNA↓, 23,   SIRT6↑, 1,   Telomerase↓, 13,   TOP1↓, 4,   TOP2↓, 3,   TOP2↑, 1,   TP53↓, 1,   TP53↑, 1,   TRF2↓, 1,   γH2AX↓, 1,   γH2AX↑, 12,   p‑γH2AX↑, 3,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 20,   CDK1↑, 2,   p‑CDK1↓, 2,   p‑CDK1↑, 1,   CDK1/2/5/9↓, 1,   CDK2↓, 38,   CDK2↑, 4,   p‑CDK2↓, 2,   CDK4↓, 43,   CDK4↑, 1,   CDK4/6↓, 1,   CDK6↓, 21,   CDK6↑, 2,   CDK8↓, 1,   CHK1↓, 2,   CHK1↑, 1,   Chk2↓, 3,   Chk2↑, 1,   ChrCon↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 14,   CycB/CCNB1↓, 31,   CycB/CCNB1↑, 7,   cycD1/CCND1↓, 82,   cycD1/CCND1↑, 1,   cycD1/CCND1↝, 1,   CycD3↓, 4,   CycD3↑, 1,   cycE/CCNE↓, 26,   cycE/CCNE↑, 1,   E2Fs↓, 2,   GADD45A↓, 1,   GADD45A↑, 1,   Ki-67↓, 23,   MAD↓, 1,   mitA↑, 3,   p19↑, 1,   P21?, 2,   P21↓, 6,   P21↑, 62,   P21↝, 1,   p27/CDKN1B↓, 3,   p27/CDKN1B↑, 28,   pRB↑, 1,   p‑pRB↓, 2,   p‑RB1↓, 7,   cl‑RB1↓, 1,   Securin↓, 1,   TubPol↓, 1,   TumCCA?, 2,   TumCCA↓, 7,   TumCCA↑, 192,   WEE1↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   p‑4E-BP1↓, 1,   ALDH↓, 4,   Axin2↑, 1,   BMI1↓, 1,   CD133↓, 2,   CD24↓, 2,   CD34↓, 1,   cFos↓, 6,   cFos↑, 1,   cMYB↓, 1,   CSCs↓, 21,   Diff↓, 1,   Diff↑, 1,   FGF↓, 5,   Gli↓, 1,   Gli1↓, 5,   HH↓, 6,   HMGCR↓, 1,   IGF-1↓, 8,   IGF-2↓, 1,   IGFBP1↑, 1,   IGFBP3↑, 3,   JAG1↓, 1,   Ki-67↓, 23,   Let-7↑, 1,   mTORC1↓, 4,   Nanog↓, 3,   Nestin↓, 1,   NICD↓, 1,   NOTCH↓, 10,   NOTCH↑, 1,   NOTCH1↓, 10,   NOTCH1↑, 1,   NOTCH2↑, 1,   NOTCH3↓, 3,   OGFr↑, 1,   p300↓, 1,   PTCH2↓, 1,   SAL↑, 1,   SCF↓, 2,   Shh↓, 7,   Smo↓, 2,   STAT1↓, 1,   Sufu↑, 1,   TAZ↓, 1,   TumCG?, 1,   TumCG↓, 77,   TumCG↑, 3,   TumCP↓, 139,   TumCP↑, 6,   tyrosinase↓, 2,   URGCP/URG4↓, 1,   Wnt↓, 23,   Wnt↑, 1,   Wnt/(β-catenin)↓, 3,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AntiAg↑, 1,   AP-1↓, 5,   AP-1↝, 1,   AXL↓, 3,   BACH1↓, 1,   Ca+2↓, 2,   Ca+2↑, 27,   Ca+2↝, 2,   i-Ca+2↑, 1,   CAFs/TAFs↓, 2,   cal2↓, 1,   cal2↑, 1,   Cav1↓, 1,   Cdc42↓, 2,   COL1↓, 1,   COL3A1↓, 1,   E-cadherin↓, 6,   E-cadherin↑, 30,   EM↑, 1,   EMT↓, 41,   EMT↑, 1,   EMT↝, 1,   EpCAM↓, 3,   F-actin↓, 1,   FAK↓, 8,   p‑FAK↓, 3,   Fibronectin↓, 3,   GLI2↓, 3,   IQGAP3↓, 1,   ITGA5↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB4↓, 1,   KRAS↓, 2,   LAMs↓, 1,   LEF1↓, 1,   MET↓, 3,   MET↑, 2,   p‑MET↓, 1,   MMP-10↓, 2,   MMP1↓, 7,   MMP13↓, 1,   MMP16↓, 1,   MMP2↓, 67,   MMP3↓, 7,   MMP7↓, 7,   MMP9↓, 74,   MMPs↓, 25,   MMPs↝, 1,   MUC4↓, 1,   N-cadherin↓, 23,   p44↓, 1,   PAI-1/SERPINE1↑, 1,   PAK1↓, 2,   pax↓, 1,   p‑pax↓, 1,   PDGF↓, 5,   Rac1↓, 4,   RECK↑, 1,   Rho↓, 4,   ROCK1↓, 2,   Slug↓, 8,   Smad1↓, 1,   p‑SMAD2↓, 1,   SMAD3↓, 3,   SMAD3↑, 1,   p‑SMAD3↓, 1,   p‑SMAD4↓, 1,   Snail?, 1,   Snail↓, 23,   TET1↓, 1,   TET1↑, 2,   TGF-β↓, 10,   TGF-β↑, 1,   TIMP1↓, 2,   TIMP1↑, 10,   TIMP2↑, 11,   TIMP3↑, 1,   TRIB3↑, 1,   TSC1↑, 1,   TSP-1↑, 2,   TumCA↑, 1,   TumCI?, 2,   TumCI↓, 56,   TumCMig?, 1,   TumCMig↓, 52,   TumMeta?, 1,   TumMeta↓, 43,   TumMeta↑, 2,   Twist↓, 14,   Tyro3↓, 1,   uPA↓, 16,   uPAR↓, 1,   Vim↓, 24,   Vim↑, 1,   Zeb1↓, 7,   Zeb1↑, 1,   ZEB2↓, 2,   α-tubulin↓, 2,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 32,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 72,   angioG↑, 1,   CD31/PECAM-1↓, 5,   ECM/TCF↓, 1,   Endoglin↑, 3,   eNOS↓, 2,   HIF-1↓, 3,   Hif1a↓, 40,   NO↓, 1,   NO↑, 4,   VCAM-1↓, 2,   VEGF↓, 82,   VEGF↑, 1,   VEGF↝, 1,   VEGFR1↓, 2,   VEGFR2/KDR/Flk1↓, 16,   p‑VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 4,   BBB∅, 1,   CLDN1↓, 2,   CLDN1↑, 1,   CLDN2↓, 1,   EPR↑, 1,   GLUT1↓, 9,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT4↓, 1,   IBI↑, 1,   MMP↓, 140,   MMP↑, 2,   MMP∅, 1,   MPT↑, 8,   NHE1↓, 1,   OCLN↑, 1,   SVCT-2↓, 1,   SVCT-2∅, 1,   TJ↑, 1,   TRPM7↓, 1,   TRPV1↑, 2,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CD25+↑, 1,   CD4+↑, 1,   CD44↓, 9,   cDC2↓, 4,   p‑cDC2↓, 2,   COX1?, 1,   COX1↓, 1,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 62,   COX2/PTGS2↑, 2,   COX2/PTGS2↝, 1,   CXCR2↓, 1,   CXCR4↓, 10,   CXCR4↑, 1,   DR4↑, 9,   DR4∅, 1,   FOXP3↑, 1,   Gal-3↓, 1,   HMGB1↓, 2,   ICAM-1↓, 2,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 1,   IL1↑, 1,   IL10↓, 2,   IL12↓, 1,   IL1α↓, 1,   IL1β↓, 10,   IL2↑, 3,   IL4↓, 1,   IL4↑, 1,   IL6↓, 27,   IL8↓, 4,   Imm↑, 4,   Imm↝, 2,   Inflam↓, 21,   LTA/TNF-β↑, 1,   M2 MC↓, 1,   MCP1/CCL2↓, 1,   MCT1↓, 1,   MIP2↓, 1,   mPGES-1↓, 1,   NF-kB↓, 102,   NF-kB↑, 4,   NF-kB↝, 1,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 1,   NLRP3↓, 1,   NLRP3↑, 1,   NOD1↓, 1,   p50↓, 1,   p65↓, 7,   p‑p65↓, 2,   ac‑p65↓, 1,   ac‑p65↑, 1,   PD-1↓, 3,   PD-1↝, 1,   PD-L1↓, 4,   PD-L1↑, 1,   PGE2↓, 14,   PSA↓, 6,   RAGE↓, 1,   SOCS-3↓, 1,   T-Cell↑, 1,   T-Cell↝, 1,   TCF↓, 1,   TCF↑, 1,   TLR4↓, 4,   TLR4↝, 1,   TNF-α↓, 26,   TNF-α↑, 4,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   IM↓, 1,   pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   SYN1↑, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 16,   ER-α36↓, 2,   ERα/ESR1↓, 1,   GR↝, 1,   PPARα↓, 2,   PPARγ↓, 2,   PPARγ↑, 4,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   ABCG2↓, 3,   BioAv↓, 28,   BioAv↑, 32,   BioAv↝, 9,   BioEnh↑, 5,   ChemoSen?, 1,   ChemoSen↓, 1,   ChemoSen↑, 105,   CompStab↓, 1,   CompStab↑, 2,   CompStab↝, 2,   CYP1A1↓, 1,   CYP1A1↑, 1,   CYP3A4↓, 2,   Dose?, 2,   Dose↓, 2,   Dose↑, 4,   Dose⇅, 1,   Dose↝, 42,   Dose∅, 10,   eff↓, 84,   eff↑, 66,   eff↝, 6,   eff∅, 1,   GSTA1↑, 1,   GSTP1/GSTπ↓, 1,   Half-Life↓, 7,   Half-Life↑, 1,   Half-Life↝, 11,   MDR1↓, 4,   MRP1/ABCC1↓, 5,   P-gp/ABCB1↓, 10,   P-gp/ABCB1↑, 1,   P450↓, 3,   RadioS?, 1,   RadioS↑, 31,   selectivity↓, 1,   selectivity↑, 96,   Synergy↑, 74,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 2,   ALAT↓, 4,   ALP↓, 2,   AR↓, 16,   ascitic↓, 1,   AST↓, 3,   BRAF↓, 2,   BRCA1↓, 1,   BRCA1↑, 1,   CEA↓, 2,   CRP↓, 1,   E6↓, 2,   E7↓, 2,   EGFR↓, 29,   EGFR↑, 2,   p‑EGFR↓, 1,   ERα/ESR1↓, 1,   EZH2↓, 2,   Ferritin↓, 1,   FOXM1↓, 3,   HER2/EBBR2↓, 14,   hTERT/TERT↓, 7,   IL6↓, 27,   KRAS↓, 2,   LDH↓, 5,   LDH↑, 4,   LDH↝, 1,   i-LDH↓, 1,   Myc↓, 4,   NSE↓, 1,   PD-L1↓, 4,   PD-L1↑, 1,   PSA↓, 6,   RAGE↓, 1,   TP53↓, 1,   TP53↑, 1,   TRIB3↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 32,   antiCG↓, 1,   antiD↑, 1,   antiNeop↑, 2,   AntiTum↓, 2,   AntiTum↑, 14,   cachexia↓, 2,   cardioP↑, 5,   CardioT↑, 1,   chemoP↑, 19,   chemoPv↑, 15,   ChemoSideEff↓, 2,   hepatoP↓, 1,   hepatoP↑, 7,   neuroP↑, 5,   NP/CIPN↓, 1,   Obesity↓, 1,   OS↑, 10,   Pain↓, 2,   QoL↑, 2,   radioP↑, 3,   Remission↑, 1,   RenoP↑, 10,   Risk↓, 10,   toxicity?, 1,   toxicity↓, 13,   toxicity↑, 4,   toxicity↝, 9,   TumNum↓, 2,   TumVol↓, 23,   TumVol↑, 1,   TumW↓, 10,   Weight↑, 1,   Weight∅, 1,   Wound Healing↓, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiP↑, 1,   Bacteria↓, 3,   GutMicro↑, 3,   GutMicro↝, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 2,  
Total Targets: 1029

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 3,   antiOx↑, 44,   i-antiOx↑, 1,   Catalase↑, 22,   GPx↑, 15,   GPx1↑, 1,   GSH↑, 16,   GSR↑, 2,   GSSG∅, 1,   GSTs↑, 9,   H2O2↓, 1,   HDL↑, 1,   HO-1↓, 1,   HO-1↑, 11,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 11,   MDA↓, 9,   MPO↓, 1,   NADH↓, 1,   NOX4↓, 1,   Nrf1↑, 1,   NRF2↓, 1,   NRF2↑, 24,   Prx↑, 1,   RNS↓, 3,   ROS↓, 47,   ROS↑, 2,   ROS∅, 4,   mt-ROS?, 1,   SOD↓, 1,   SOD↑, 22,   SOD1↑, 2,   SOD2↑, 2,   TAC↑, 2,   TBARS↓, 1,   uricA↓, 1,   VitC↑, 1,   VitE↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↑, 2,   PGC-1α↑, 1,   PGC-1α↝, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 2,   ALAT↓, 4,   AMPK↑, 2,   ATP↑, 3,   GAPDH↑, 1,   glucose↓, 4,   glucose↝, 1,   GSK‐3β↓, 2,   LDL↓, 4,   lipidLev↓, 1,   NAD↑, 1,   NADPH↑, 2,   SIRT1↑, 2,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   Apoptosis↓, 6,   Apoptosis∅, 1,   mt-Apoptosis↓, 1,   BAX↓, 5,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 2,   Bcl-2↑, 4,   Casp↓, 1,   Casp1↓, 1,   Casp12↓, 1,   Casp3?, 1,   Casp3↓, 7,   Casp3↑, 1,   Casp3∅, 1,   cl‑Casp3↓, 1,   cl‑Casp3↑, 1,   proCasp3↑, 1,   Casp8↑, 1,   cl‑Casp8↑, 2,   Casp9↓, 1,   Casp9↑, 1,   Casp9∅, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 1,   Cyt‑c↓, 4,   Cyt‑c∅, 1,   Fas↑, 2,   iNOS↓, 9,   iNOS↑, 1,   p38↓, 3,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 1,   p‑Akt↑, 1,   Akt2↓, 1,   ERK↓, 1,   ERK↑, 1,   IGF-1R↓, 1,   IKKα↓, 1,   IκB?, 1,   JAK↓, 1,   JNK↓, 3,   JNK↑, 1,   p‑JNK↓, 2,   MAPK↓, 4,   MAPK↑, 1,   mTOR↓, 1,   mTOR↑, 1,   PDGFR-BB↓, 1,   PI3K↓, 2,   PI3K↑, 1,   PKCδ↓, 1,   STAT3↑, 1,   p‑STAT3↑, 1,   STAT6↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   p‑cMyc↑, 1,   HOTAIR↑, 1,   other↓, 2,   other↑, 1,   other↝, 1,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   ER Stress↓, 1,   GRP78/BiP↓, 1,   HSP70/HSPA5↑, 1,   IRE1↓, 1,   PERK↓, 1,   UPR↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↑, 1,   LC3II↑, 1,   p62↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   p16↓, 1,   P53↓, 3,   P53↑, 2,   PARP↓, 3,   PARP↑, 1,   PARP∅, 1,   p‑PARP↓, 1,   cl‑PARP↓, 3,   cl‑PARP↑, 2,   PARP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   cycA1/CCNA1↓, 1,   cycE/CCNE↑, 1,   E2Fs↑, 1,   P21↓, 2,   P21↑, 3,   TumCCA↑, 3,  

Migration(tgid=13) ⓘ

AntiAg↑, 6,   AP-1↓, 1,   Ca+2?, 1,   Ca+2↓, 2,   Ca+2↝, 1,   MLC2/MYL9↝, 1,   MMP13↓, 2,   MMP2↓, 1,   MMP3↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   E-sel↓, 1,   Hif1a↓, 2,   NO↓, 6,   NO↑, 1,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 5,   GastroP↑, 2,   GLUT1↓, 1,   MMP↓, 3,   MMP↑, 3,   MMP∅, 1,   MUC5AC↓, 1,   OCLN↝, 1,   SVCT-2↑, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPC1↓, 1,   TRPV1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   CD4+↑, 1,   CD8+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 16,   COX2/PTGS2↑, 1,   IL10↓, 2,   IL10↑, 1,   IL17↓, 1,   IL18↓, 1,   IL1β↓, 10,   IL6↓, 14,   IL6↑, 1,   IL8↓, 1,   Imm↑, 4,   Imm⇅, 1,   Inflam↓, 52,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 1,   MyD88↓, 1,   NeuroI↓, 1,   NF-kB↓, 18,   NLRP3↓, 1,   PAF↓, 1,   PGE2↓, 4,   PGE2↑, 1,   PSA∅, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR1↓, 1,   TLR4↓, 1,   TNF-α↓, 21,   β-HEX↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 5,   BChE↓, 2,   BDNF↑, 2,   MAOA↓, 1,   NGF↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 6,   BACE/β-secretase↓, 2,   tau↓, 2,   p‑tau↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

Estro↓, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 17,   BioAv↑, 24,   BioAv↝, 10,   BioAv∅, 1,   BioEnh↑, 1,   CompStab↑, 1,   Dose↝, 5,   Dose∅, 1,   eff↑, 6,   GSTA1↑, 1,   Half-Life↑, 1,   Half-Life↝, 8,   Half-Life∅, 2,   P450↑, 1,   Synergy↑, 4,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 4,   ALP↓, 2,   AST↓, 5,   BG↓, 1,   BP↓, 4,   creat↓, 1,   CRP↓, 3,   hs-CRP↓, 1,   IL6↓, 14,   IL6↑, 1,   LDH↓, 4,   LDH↑, 1,   NOS2↓, 1,   PSA∅, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 3,   antiAll↑, 14,   AntiArt↑, 7,   AntiCan↑, 9,   antiCG↑, 1,   AntiDiabetic↑, 9,   antiPs↑, 2,   AntiTum↓, 1,   AntiTum↑, 4,   cardioP↑, 17,   chemoP↑, 7,   chemoPv↑, 2,   cognitive↑, 4,   hepatoP↓, 1,   hepatoP↑, 10,   memory↑, 4,   motorD↓, 1,   motorD↑, 1,   neuroP↓, 1,   neuroP↑, 30,   Obesity↓, 6,   Pain↓, 4,   radioP↑, 3,   RenoP↑, 2,   Stress↓, 1,   Stroke↓, 5,   toxicity↓, 24,   toxicity↑, 2,   toxicity↝, 4,   toxicity∅, 4,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 9,   AntiFungal↓, 1,   AntiFungal↑, 2,   AntiP↓, 1,   AntiP↑, 2,   AntiViral↑, 12,   Bacteria↓, 13,   GutMicro↑, 9,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 5,  
Total Targets: 296

Scientific Paper Hit Count for: PARP, poly ADP-ribose polymerase (PARP) cleavage
16 Apigenin (mainly Parsley)
16 Curcumin
15 Fisetin
14 Quercetin
14 Thymoquinone
12 Baicalein
10 EGCG (Epigallocatechin Gallate)
10 Sulforaphane (mainly Broccoli)
8 Honokiol
8 Kaempferol
8 Licochalcone A
8 Shikonin
7 Ashwagandha(Withaferin A)
7 Berberine
7 Capsaicin
7 Emodin
7 Garcinol
7 Magnolol
6 Metformin
6 Boswellia (frankincense)
6 Carnosic acid
6 Chrysin
6 Gambogic Acid
6 isoorientin
6 lambertianic acid
6 Piperlongumine
6 Vitamin C (Ascorbic Acid)
5 doxorubicin
5 Cisplatin
5 Betulinic acid
5 Benzyl isothiocyanate
5 Eugenol
5 Isorhamnetin
5 Licorice
5 Morin
5 Silymarin (Milk Thistle) silibinin
4 5-fluorouracil
4 Bufalin/Huachansu
4 α-Bisabolol / Chamomile oil
4 Carvacrol
4 chaetocin
4 Citric Acid
4 Docetaxel
4 Evodiamine
4 Formononetin
4 Fucoidan
4 Ginkgetin
4 Ivermectin
4 Nimbolide
4 Propolis -bee glue
4 Phenethyl isothiocyanate
4 Resveratrol
3 Auranofin
3 Silver-NanoParticles
3 Allicin (mainly Garlic)
3 Brucea javanica
3 Thymol-Thymus vulgaris
3 Radiotherapy/Radiation
3 Ellagic acid
3 Ferulic acid
3 HydroxyTyrosol
3 Isobavachalcone
3 phytic acid, Inositol hexakisphosphate
3 Isoliquiritigenin
3 Luteolin
3 Lycopene
3 mebendazole
3 Magnetic Fields
3 Methylsulfonylmethane
3 Propyl gallate
3 α-Santalol/Sandalwood oil
2 1,8-Cineole
2 Artemisinin
2 Berbamine
2 Beta-Caryophyllene
2 temozolomide
2 brusatol
2 Boron
2 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
2 Cichoric acid / Chicoric acid
2 Cinnamon
2 Cucurbitacin
2 Cynaropicrin
2 Dichloroacetate
2 D-limonene
2 Dandelion Root
2 Echinacea
2 Ginkgo biloba-EGb 761
2 Eurycomanone
2 Flaxseed/Linseed
2 Gallic acid
2 Photodynamic Therapy
2 Hyperoside
2 Rutin
2 Indole-3-carbinol
2 isoquercitrin
2 Juglone
2 methylseleninic acid
2 Phenylbutyrate
2 Paclitaxel/Taxol
2 Piperine
2 Rosmarinic acid
2 salinomycin
2 Selenite (Sodium)
2 Ursolic acid
2 Urolithin
2 Zyflamend
1 3-bromopyruvate
1 Allyl isothiocyanate
1 DTS(dibenzyl trisulphide) from Anamu
1 Anethole/trans-Anethole
1 Fennel Oil/Foeniculum vulgare
1 immunotherapy
1 Atorvastatin
1 Aloe anthraquinones
1 Baicalin
1 almonertinib
1 Bromelain
1 Beetroot
1 Bullatacin
1 Butyrate
1 Sorafenib (brand name Nexavar)
1 Cat’s Claw
1 Celastrol
1 Chlorogenic acid
1 Chlorophyllin
1 Coenzyme Q10
1 Cranberry
1 Carvone
1 Dichloroacetophenone(2,2-)
1 Date Fruit Extract
1 Diindolylmethane
1 Fenbendazole
1 Geldanamycin
1 Radicicol/monorden
1 Bortezomib
1 Flaxseed Oil
1 olaparib/LYNPARZA
1 Gemcitabine (Gemzar)
1 Ginkgolic acids
1 Genistein (soy isoflavone)
1 Ginkgolide B
1 Ginger/6-Shogaol/Gingerol
1 Gossypol/AT-101
1 Graviola
1 Hydroxycinnamic-acid
1 hydroxychloroquine
1 carboplatin
1 isoflavones
1 Isovitexin
1 L-Theanine
1 tumor necrosis factor-related apoptosis-inducing ligand
1 Lapachol
1 Lasiodin
1 low dose naltrexone
1 Linalool
1 Lutein
1 Methylene blue
1 Matrine
1 Dordaviprone; Modeyso
1 Modified Citrus Pectin
1 Chemotherapy
1 Mangiferin
1 Mistletoe/Viscum album Extracts
1 Mushroom Chaga, Inonotus obliquus
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Myricetin
1 nelfinavir/Viracept
1 Oleuropein
1 Marjoram (Origanum majorana)
1 Patchouli Oil (Pogostemon cablin)
1 SonoDynamic Therapy UltraSound
1 Hyperthermia
1 Phycocyanin
1 Plumbagin
1 VitK3,menadione
1 Rauwolfia serpentina/Indian Snakeroot
1 buckwheat sprouts
1 Selenium NanoParticles
1 chitosan
1 Folic Acid, Vit B9
1 Osimertinib
1 Adagrasib
1 Terpinen-4-ol / Tea Tree Oil
1 Aflavin-3,3′-digallate
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:239  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page